Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GLP-1 receptor agonists, cancer risk and questionable significance

2.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

3.

Pancreatic cancer RNA vaccine shows durable T cell immunity

4.

Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer

5.

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot